[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 44, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1179148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 49, "title": "CFO & Treasurer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 691583, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 43, "title": "General Counsel & Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 577338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 48, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 41, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 57.43, "open": 57.34, "dayLow": 55.37, "dayHigh": 61.44, "regularMarketPreviousClose": 57.43, "regularMarketOpen": 57.34, "regularMarketDayLow": 55.37, "regularMarketDayHigh": 61.44, "beta": 2.741, "forwardPE": -7.287246, "volume": 250645, "regularMarketVolume": 250645, "averageVolume": 262306, "averageVolume10days": 259300, "averageDailyVolume10Day": 259300, "bid": 61.07, "ask": 61.47, "bidSize": 100, "askSize": 100, "marketCap": 1085669120, "fiftyTwoWeekLow": 13.005, "fiftyTwoWeekHigh": 67.21, "priceToSalesTrailing12Months": 613.02606, "fiftyDayAverage": 55.8854, "twoHundredDayAverage": 47.43085, "currency": "USD", "enterpriseValue": 735734208, "floatShares": 13115726, "sharesOutstanding": 17757100, "sharesShort": 1902729, "sharesShortPriorMonth": 1860927, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.107200004, "heldPercentInsiders": 0.0026, "heldPercentInstitutions": 1.07033, "shortRatio": 7.62, "shortPercentOfFloat": 0.1073, "impliedSharesOutstanding": 17784700, "bookValue": 23.604, "priceToBook": 2.5902388, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -123740000, "trailingEps": -5.59, "forwardEps": -8.39, "pegRatio": 0.47, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 415.434, "enterpriseToEbitda": -5.563, "52WeekChange": 1.470303, "SandP52WeekChange": 0.34083736, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PRAX", "underlyingSymbol": "PRAX", "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "firstTradeDateEpochUtc": 1602855000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d9e1bd55-646b-3409-879b-a7984b5b3499", "messageBoardId": "finmb_409236524", "gmtOffSetMilliseconds": -14400000, "currentPrice": 61.14, "targetHighPrice": 270.0, "targetLowPrice": 51.0, "targetMeanPrice": 146.44, "targetMedianPrice": 146.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 351879008, "totalCashPerShare": 19.816, "ebitda": -132257000, "totalDebt": 1946000, "quickRatio": 17.065, "currentRatio": 17.3, "totalRevenue": 1771000, "debtToEquity": 0.464, "revenuePerShare": 0.139, "returnOnAssets": -0.28869, "returnOnEquity": -0.47164002, "freeCashflow": -53949000, "operatingCashflow": -95211000, "revenueGrowth": -0.543, "operatingMargins": -105.0084, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]